For the Inventor, By the Inventor

Enter assignee name

Watertown, MA, United States of America

Selecta Biosciences, Inc.

USPTO Granted Patents = 32

% Expired Patents = 28.1

EPO Patents = 14

Trademarks = 2

Forward Citations = 672

Loading Chart...

Loading Chart...

15 inventors (with patents filed for the assignee):

Roberto A Maldonado (19 out of 19 patents)

Takashi Kei Kishimoto (14 out of 26 patents)

Christopher C Fraser (11 out of 26 patents)

4. Grayson B Lipford (8 out of 23 patents)

5. Charles M Zepp (6 out of 57 patents)

6. Yun Gao (4 out of 40 patents)

7. Lloyd Johnston (4 out of 17 patents)

8. David H Altreuter (3 out of 9 patents)

9. Petr Ilyinskii (3 out of 3 patents)

10. Fen-ni Fu (3 out of 3 patents)

11. Mark J Keegan (3 out of 3 patents)

12. Sam Baldwin (3 out of 5 patents)

13. Aaron P Griset (2 out of 2 patents)

14. Christopher J Roy (2 out of 2 patents)

15. Conlin O'Neil (1 out of 1 patent)

Core Competencies:

Tolerogenic

Synthetic Nanocarriers

Immunosuppressants

Allergy Therapy

Antigen-Specific Tolerance

Regulatory T Cells

Cytotoxic T Lymphocyte

Humoral Immune Responses

Therapeutic Macromolecules

Immunomodulatory Agents

Adjuvanted Nanocarriers

Nicotinic Compounds

32 patents: Sort by Forward Citations

1. 11779641 - Tolerogenic synthetic nanocarriers for allergy therapy (2023-10-10),

2. 11717569 - Tolerogenic synthetic nanocarriers (2023-08-08),

3. 11633422 - Methods and compositions for attenuating anti-viral transfer vector immune responses (2023-04-25),

4. 11426451 - Methods and compositions related to combined treatment with antiinflammatories and synthetic nanocarriers comprising an immunosuppressant (2022-08-30),

5. 11298342 - Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity (2022-04-12),

6. 11235057 - Methods for providing polymeric synthetic nanocarriers for generating antigen-specific tolerance immune responses (2022-02-01),

7. 10933129 - Methods for administering synthetic nanocarriers that generate humoral and cytotoxic T lymphocyte responses (2021-03-02),

8. 10668053 - Tolerogenic synthetic nanocarriers to reduce or prevent anaphylaxis in response to a non-allergenic antigen (2020-06-02),

9. 10441651 - Tolerogenic synthetic nanocarriers for generating CD8+ regulatory T cells (2019-10-15),

10. 10434088 - Methods related to administering immunosuppressants and therapeutic macromolecules at a reduced pharmacodynamically effective dose (2019-10-08),

11. 10420835 - Tolerogenic synthetic nanocarriers for antigen-specific deletion of T effector cells (2019-09-24),

12. 10357483 - Methods comprising dosing combinations for reducing undesired humoral immune responses (2019-07-23),

13. 10357482 - Methods providing a therapeutic macromolecule and synthetic nanocarriers comprising immunosuppressant locally and concomitantly to reduce both type I and type IV hypersensitivity (2019-07-23),

14. 10335395 - Methods of administering immunosuppressants having a specified pharmacodynamic effective life and therapeutic macromolecules for the induction of immune tolerance (2019-07-02),

15. 10071114 - Methods and compositions for attenuating gene expression modulating anti-viral transfer vector immune responses (2018-09-11),

Company Overview

Selecta Biosciences, Inc. is a biotechnology company based in Watertown, MA, specializing in the development of innovative therapies that harness the power of the immune system. The company focuses on its proprietary ImmTOR platform, which aims to induce immune tolerance for the treatment of various diseases, including rare genetic disorders and autoimmune conditions. Selecta's research is centered on advancing biologics and gene therapies, positioning it at the forefront of transformative medical solutions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

32 Patents

#15 in Watertown, MA

#637 in Massachusetts

#10,599 in US

#20,671 in the World

Watertown, MA, United States of America

Selecta Biosciences, Inc.

Forward Citations = 672

15 inventors:

Roberto A Maldonado (19 out of 19 patents)

Takashi Kei Kishimoto (14 out of 26 patents)

Christopher C Fraser (11 out of 26 patents)

4. Grayson B Lipford (8 out of 23 patents)

5. Charles M Zepp (6 out of 57 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Selecta Biosciences, Inc.. Retrieved from https://idiyas.com/company/selecta-biosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…